🇺🇸 FDA
Patent

US 9216178

Dry blend formulation of tetrahydrobiopterin

granted A61KA61K31/405A61K31/519

Quick answer

US patent 9216178 (Dry blend formulation of tetrahydrobiopterin) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/405, A61K31/519, A61K9/0053, A61K9/009